Dow Down 0.17% Nasdaq Down 0.28%

Pain Therapeutics Inc. (PTIE)

-NasdaqGS
3.91 Sep 30, 4:00PM EDT
Prev Close:3.91
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:8.00
Beta:1.51
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:N/A - N/A
52wk Range:2.58 - 6.22
Volume:0
Avg Vol (3m):197,750
Market Cap:178.91M
P/E (ttm):6.91
EPS (ttm):0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PTIE 0.00%178.91M
ABT62.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Mar-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs. Its lead drug candidate is REMOXY (oxycodone) Extended-Release Capsules CII, an investigational drug with a controlled release formulation of oxycodone for patients with m... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback